ACAD — ACADIA Pharmaceuticals Inc. stock price, charts and financials

QT68ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.15
+1.54+6.01%
OverviewShort InterestFilings
ACADQT68ACADIA Pharmaceuticals Inc.·NASDAQ
27.15+6.01%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20268-KCurrent report
Jul 31, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 10, 2026S-8Registration of employee benefit securities
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 05, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
Apr 28, 2026SC 13GBeneficial ownership statement (passive)
Apr 24, 2026DEF 14ADefinitive proxy statement
Apr 24, 2026ARSAnnual report to shareholders
Apr 07, 20264Statement of changes in beneficial ownership
Apr 07, 20264Statement of changes in beneficial ownership
Mar 26, 20264Statement of changes in beneficial ownership
Mar 26, 20264Statement of changes in beneficial ownership
Mar 26, 20264Statement of changes in beneficial ownership
#1 / 25 of 337
Page
▼
/ 14